CHANGES IN OWNERSHIP INTEREST IN CONSOLIDATED SUBSIDIARIES (Tables)

6 Months Ended

Jun. 30, 2020

Noncontrolling Interest [Abstract]

Schedule of effect of changes in company's ownership interest on company's equity

The effects of changes in the Company’s ownership interest in consolidated subsidiaries on the Company’s equity are as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2020		2019		2020		2019
Net income (loss) attributable to American Renal Holdings Associates, Inc.	$	795	$	(8,178)	$	(6,439)	$	(18,657)
Increase in paid-in capital for the sales of noncontrolling interest	—		—		3,448		—
Decrease in paid-in capital for the purchase of noncontrolling interest and adjustments to ownership interest	(886)		(7,590)		(886)		(7,540)
Net transfers to/from noncontrolling interests	$	(886)	$	(7,590)	$	2,562	$	(7,540)
Net loss attributable to American Renal Holdings Associates, Inc., net of transfers to/from noncontrolling interests	$	(91)	$	(15,768)	$	(3,877)	$	(26,197)